Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Novartis dumps worldwide rights to an Aveo drug, and the little biotech is not happy with them
Endpoints
Tue, 07/3/18 - 11:18 am
Tags:
Novartis, Aveo, GDF15, AV-380
Novartis steps in to compete with Mylan’s Epipen
Drug Delivery Business News
Mon, 07/2/18 - 09:27 am
Tags:
Adamis Pharmaceuticals, Novartis, Sandoz, Symjepi, Mylan, EpiPens
Novartis chairman says Alcon worth $20 billion -$30 billion - Finanz und Wirtschaft
Yahoo/Reuters
Sat, 06/30/18 - 12:13 pm
Tags:
Novartis, Alcon, M&A
Novartis to spin out Alcon ophthalmic subsidiary
Mass Device
Fri, 06/29/18 - 11:21 am
Tags:
Novartis, Alcon, opthalmology, eye health, devices, spinoffs
Touting PhIII success for arthritis drug Taltz, Eli Lilly chases rival Novartis in heated immunology race
Endpoints
Thu, 06/28/18 - 09:45 am
Tags:
Eli Lilly, Taltz, Novartis, ankylosing spondylitis, Cosentyx
Novartis pads Cosentyx's psoriatic arthritis lead with joint-damage label update
Fierce Pharma
Thu, 06/21/18 - 11:57 am
Tags:
Novartis, Cosentyx, psoriatic arthritis
5 Experimental New Drugs That Could Be Worth $47 Billion
Motley Fool
Wed, 06/20/18 - 09:26 am
Tags:
GSK2857916, GSK, brolucizumab, Novartis, aducanumab, Biogen, upadacatinib, AbbVie, VX-659 + tezacaftor + ivacaftor, Vertex Pharmaceuticals
Novartis touts effectiveness, safety of autoimmune drug copies
Yahoo/Reuters
Fri, 06/15/18 - 09:57 am
Tags:
Novartis, biosimilars, JNJ, Remicade, Amgen, Enbrel, autoimmune disease
Amid tough competition, Novartis makes case for rheumatology drug Cosentyx
Pharmaforum
Thu, 06/14/18 - 10:35 pm
Tags:
Novartis, Cosentyx, ankylosing spondylitis
Is the future of therapy online? Swiss drug giant Novartis thinks so
Marketwatch
Wed, 06/13/18 - 09:39 am
Tags:
Novartis, Pear Therapeutics, digital therapeutics
Swiss Won’t Investigate Novartis Over Payments to Cohen
Bloomberg
Thu, 06/7/18 - 11:30 am
Tags:
Novartis, Switzerland, Donald Trump, Michael Cohen
Migraine Breakthrough: Not So Fast
Forbes
Wed, 06/6/18 - 09:49 pm
Tags:
Amgen, Novartis, Aimovig, migraines, adults, monoclonal antibodies
ASCO: Novartis makes a case for earlier Kisqali use. Will 'conservative' docs run with it?
Fierce Pharma
Mon, 06/4/18 - 09:31 am
Tags:
Novartis, Kisqali, metastatic breast cancer, ASCO 2018, HR-positive, HER2-negative breast cancer
NTC acquires part of Novartis’ ophthalmic portfolio
GoinPharma
Sat, 06/2/18 - 01:46 pm
Tags:
Novartis, NTC, ophthalmology, M&A
How Novartis, Insurers Are Taking Wind Out Of AbbVie's Sales
Investors Business Daily
Fri, 06/1/18 - 10:43 pm
Tags:
AbbVie, Novartis, Humira, biosimilars, Europe, CHMP
Novartis receives EU approval for biosimilar Zessly
Reuters
Thu, 05/24/18 - 09:38 pm
Tags:
Novartis, Sandoz, biosimilars, Europe, Zessly
Novartis' brand-new gene therapy player AveXis will build $55M plant, hire 200
Fierce Pharma
Wed, 05/23/18 - 03:03 pm
Tags:
Novartis, AveXis, gene therapy, drug manufacturing
Cohen scandal disrupts ex-Novartis CEO's move to hedge fund board: WSJ
Fierce Pharma
Tue, 05/22/18 - 06:09 pm
Tags:
Novartis, Joe Jimenez, Donald Trump, Michael Cohen
Breast Cancer Cells Use In-House Recycling To Survive After Spreading
Forbes
Tue, 05/22/18 - 06:03 pm
Tags:
breast cancer, metastatic breast cancer, autophagy, Novartis, Pfizer
Migraine prevention drug could be worth $1 to $2 billion over next five years: Wall Street analyst
CNBC
Sat, 05/19/18 - 11:30 am
Tags:
migraines, Amgen, Novartis, Aimovig

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.